Enhancement of human adipose-derived stromal cell angiogenesis through knockdown of a BMP-2 inhibitor

Benjamin Levi*, Emily R. Nelson, Jeong S. Hyun, Jason P. Glotzbach, Shuli Li, Allison Nauta, Daniel T. Montoro, Min Lee, George C. Commons, Shijun Hu, Joseph C. Wu, Geoffrey C. Gurtner, Michael T. Longaker

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

27 Scopus citations

Abstract

BACKGROUND: Previous studies have demonstrated the role of noggin, a bone morphogenetic protein-2 inhibitor, in vascular development and angiogenesis. The authors hypothesized that noggin suppression in human adipose-derived stromal cells would enhance vascular endothelial growth factor secretion and angiogenesis in vitro and in vivo to a greater extent than bone morphogenetic protein-2 alone. METHODS: Human adipose-derived stromal cells were isolated from human lipoaspirate (n = 6) noggin was knocked down using lentiviral techniques. Knockdown was confirmed and angiogenesis was assessed by tubule formation and quantitative real-time polymerase chain reaction. Cells were seeded onto scaffolds and implanted into a 4-mm critical size calvarial defect. In vivo angiogenic signaling was assessed by immunofluorescence and immunohistochemistry. RESULTS: Human adipose-derived stromal cells with noggin suppression secreted significantly higher amounts of angiogenic proteins, expressed higher levels of angiogenic genes, and formed more tubules in vitro. In vivo, calvarial defects seeded with noggin shRNA human adipose-derived stromal cells exhibited a significantly higher number of vessels in the defect site than controls by immunohistochemistry (p < 0.05). In addition, bone morphogenetic protein-2-releasing scaffolds significantly enhanced vascular signaling in the defect site. CONCLUSIONS: Human adipose-derived stromal cells demonstrate significant increases in angiogenesis in vitro and in vivo with both noggin suppression and BMP-2 supplementation. By creating a cell with noggin suppressed and by using a scaffold with increased bone morphogenetic protein-2 signaling, a more angiogenic niche can be created.

Original languageEnglish
Pages (from-to)53-66
Number of pages14
JournalPlastic and Reconstructive Surgery
Volume129
Issue number1
DOIs
StatePublished - Jan 2012
Externally publishedYes

Fingerprint

Dive into the research topics of 'Enhancement of human adipose-derived stromal cell angiogenesis through knockdown of a BMP-2 inhibitor'. Together they form a unique fingerprint.

Cite this